| Hans-Günter Meyer-Thompson | Buprenorphin
Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations
Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations
Neale et al.
Harm Reduction Journal (2019) 16:25, doi.org/10.1186/s12954-019-0296-4